# A Multi-centre, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)

> **NCT02859519** · PHASE3 · COMPLETED · sponsor: **Moberg Pharma AB** · enrollment: 365 (actual)

## Conditions studied

- Distal Subungual Onychomycosis

## Interventions

- **DRUG:** MOB015B
- **DRUG:** MOB015B Vehicle

## Key facts

- **NCT ID:** NCT02859519
- **Lead sponsor:** Moberg Pharma AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2019-11-13
- **Final completion:** 2019-11-13
- **Target enrollment:** 365 (ACTUAL)
- **Last updated:** 2020-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02859519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02859519, "A Multi-centre, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02859519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*